Please login to the form below

Not currently logged in
Email:
Password:

Lilly's Alimta patent confirmed

A US District Court has confirmed the validity of Eli Lilly's patent for Alimta – a drug used in chemotherapy

The US District Court for the District of Delaware has confirmed the validity of Eli Lilly's patent for Alimta (pemetrexed) – a drug used in chemotherapy.

In the case of Eli Lilly and Company et al v. Teva Parenteral Medicines Inc, the court ruled that Lilly's patent provide protection for Alimta in the US until July 2016. The case followed Teva's abbreviated new drug application (ANDA) to manufacture a generic version of Alimta.

Alimta, used in the treatment of malignant pleural mesothelioma and non-small-cell lung cancer (NSCLC), achieved global sales of $1.64bn over the first three quarters of 2010.

"We are pleased that the District Court has now confirmed the validity of Alimta's compound patent," said Robert A Armitage, senior vice president and general counsel for Lilly. "We continue to emphasise that protection of intellectual property rights is extremely important to the biopharmaceutical industry and the patients we serve.

"These rights provide assurances of market exclusivity that help support the development of the next generation of innovative medicines to treat unmet medical needs."

16th November 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics